Table I.
CR or PR | No response | |
---|---|---|
No. of patients | N = 26 | N = 17 |
Tumour size (median) (cm) | 6 | 6 |
Stage | ||
IIA(T2N1M0, T3N0M0) | 8 (31%) | 5 (29%) |
IIIA(T0N2M0, T1N2M0, T2N2M0, T3N1M0, T3N2M0) | 9 (35%) | 6 (35%) |
IIIB (T4Any NM0) | 9 (35%) | 6 (35%) |
Inflammatory | 9 (35%) | 5 (29%) |
ER+ and/or PR+ | 21 (81%) | 16 (94%) |
Her2/neu+ | 6 (23%) | 5 (29%) |